Clinical Trials Directory

Trials / Completed

CompletedNCT05965063

The Role of Bifidobacterium Intervention in Food Allergic Infants

Evaluation of the Influence of Bifidobacterium on the Infants With Food Allergic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
0 Months – 12 Months
Healthy volunteers
Accepted

Summary

Infant food protein allergy is the most common allergic disease in children, which can lead to infantile-specific dermatitis, intestinal inflammation, and so on. Dietary avoidance is a common strategy for food protein allergy in infants and young children. However, the hidden etiology of food protein allergy or multiple food allergies often leads to poor efficacy. The aim of this study is to observe the clinical effectiveness of Bifidobacterium intervention on food allergy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBifidobacterium M-16VBifidobacterium M-16V was dosed at 10 billion colony forming unit (CFU) (equal to 6 drops)/day for 12 weeks.
OTHERallergy food avoidancestrict avoidance of the specific allergenic food

Timeline

Start date
2023-09-01
Primary completion
2024-12-31
Completion
2025-03-31
First posted
2023-07-28
Last updated
2025-04-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05965063. Inclusion in this directory is not an endorsement.